298 related articles for article (PubMed ID: 33095310)
21. Porto-sinusoidal vascular disorder (PSVD): Application of new diagnostic criteria in a multicenter cohort of patients.
Gioia S; Baiocchini A; d'Amati G; Tavano D; Ridola L; Nardelli S; de Felice I; Lapenna L; Merli M; Pellicelli A; Giannelli V; Riggio O
Dig Liver Dis; 2024 Feb; 56(2):291-296. PubMed ID: 37550100
[TBL] [Abstract][Full Text] [Related]
22. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD.
Bastati N; Beer L; Ba-Ssalamah A; Poetter-Lang S; Ambros R; Kristic A; Lauber D; Pomej K; Binter T; Simbrunner B; Semmler G; Balcar L; Bican Y; Hodge JC; Wrba T; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2022 Oct; 77(4):1005-1013. PubMed ID: 35525337
[TBL] [Abstract][Full Text] [Related]
23. Porto-sinusoidal Vascular Disease and Portal Hypertension.
Noble S; Linz M; Correia E; Shalaby A; Bittencourt LK; Sclair SN
Clin Liver Dis; 2024 Aug; 28(3):455-466. PubMed ID: 38945637
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
25. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
26. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.
Wöran K; Semmler G; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Stättermayer AF; Schwabl P; Bucsics T; Paternostro R; Lampichler K; Pinter M; Trauner M; Mandorfer M; Stift J; Reiberger T; Scheiner B
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e251-e266. PubMed ID: 33279774
[TBL] [Abstract][Full Text] [Related]
27. Application of ultrasonography-elastography score to suspect porto-sinusoidal vascular disease in patients with portal vein thrombosis.
Gioia S; De Santis A; d'Amati G; Nardelli S; Spagnoli A; Rocco AD; Ridola L; Riggio O
Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):20-24. PubMed ID: 37468349
[TBL] [Abstract][Full Text] [Related]
28. Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
Gu K; Jeon TY; Yoo SY; Kim JH
Eur Radiol; 2021 Jan; 31(1):283-291. PubMed ID: 32797310
[TBL] [Abstract][Full Text] [Related]
29. Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension.
Zhang X; Durham KM; Garza AA; Murali AR
J Gastroenterol; 2023 Mar; 58(3):268-276. PubMed ID: 36692825
[TBL] [Abstract][Full Text] [Related]
30. Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis.
Zhao ZL; Wei Y; Wang TL; Peng LL; Li Y; Yu MA
Sci Rep; 2020 Feb; 10(1):2473. PubMed ID: 32051517
[TBL] [Abstract][Full Text] [Related]
31. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
[TBL] [Abstract][Full Text] [Related]
32. Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.
Hernández-Gea V; Campreciós G; Betancourt F; Pérez-Campuzano V; Seijo S; Díaz A; Gallego-Durán R; Olivas P; Orts L; Magaz M; Baiges A; Turon F; Sidorova J; Romero-Gómez M; Lozano JJ; García-Pagán JC
J Hepatol; 2021 Oct; 75(4):924-934. PubMed ID: 34052252
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X
Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293
[TBL] [Abstract][Full Text] [Related]
34. Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension.
Gioia S; Carnevale R; Tavano D; Overi D; Ridola L; Nardelli S; Merli M; d'Amati G; Pellicelli A; Cardinale V; Giannelli V; Baiocchini A; Riggio O; Gaudio E; Carpino G
Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1205-1216. PubMed ID: 37728001
[TBL] [Abstract][Full Text] [Related]
35. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
36. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation.
Krishnan P; Fiel MI; Rosenkrantz AB; Hajdu CH; Schiano TD; Oyfe I; Taouli B
AJR Am J Roentgenol; 2012 Feb; 198(2):370-6. PubMed ID: 22268180
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
38. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
[TBL] [Abstract][Full Text] [Related]
39. Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance.
Premkumar M; Anand AC
J Clin Exp Hepatol; 2024; 14(5):101396. PubMed ID: 38601747
[TBL] [Abstract][Full Text] [Related]
40. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
